The FDA has approved adding use in treatment of spinal cord injury to the indications for the neuropathic pain drug pregabalin (Lyrica).

The new indication makes pregabalin the first FDA-approved treatment for neuropathic pain from spinal cord injury, according to a statement from drug maker Pfizer.

The drug is already approved to treat diabetic nerve pain, pain after shingles, fibromyalgia, and partial-onset seizures in epileptic adults taking one or more seizure drugs. [Read more…]